Dioseve Inc.
PrivateLast Round
Series A
Extension
Jun 17, 2026
Total Funding Raised
$17M
Momentum Score
25 /100
Company Overview
Dioseve Inc. is a Japanese biotechnology company founded in 2021 that is developing assisted reproductive technology using oocytes derived from induced pluripotent stem cells (iPS cells). The company's proprietary technology aims to produce oocytes in large quantities at a low cost, offering new solutions for infertility treatment. Dioseve has raised approximately $10 million in total funding, including a $7 million Series A round in June 2024, to advance its research and global expansion. The company is headquartered in Tokyo, Japan, and has offices in Kumamoto, Japan, and Palo Alto, California, USA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dioseve Inc. Comps
Public and private peers based on sector, stage, and business model.
Dioseve Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 17, 2026 | ||||
| Series A | Jun 27, 2024 | ||||
| Seed | Aug 22, 2022 |
Dioseve Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coral Capital | Seed |
| Shionogi & Co. | Series A Extension |
| D4V (Design for Ventures) | Series A Extension |
| DG Daiwa Ventures | Series A Extension, Series A |
| ANRI株式会社 | Series A, Seed |
| Miraidoa | Series A Extension, Series A |
| Spiral Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Led by Shionogi & Co.
- Apr 1, 2026
Assisted reproductive technology using iPS cells has entered the clinical research phase.
Dioseve Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dioseve Inc.'s valuation, stock price, and market status.
